| Company profile | FUSE-AI develops AI-solutions and tools to raise diagnostic image recognition to a new level: tailored to boost efficiency, improve user experience and facilitate deeper predictive insights.
Specialized in computer vision methods, we develop AI software to support radiologists in the detection of suspicious regions on MRI and CT images faster and more safely for various indications like prostate-cancer.
FUSE-AI is listed as a medical device manufacturer and distributer in Europe by the Federal Institute for Drugs and Medical Devices (BfArM).
We are located in Hamburg, Germany and develop software according to ISO 13485.
We were involved in the development of a European DIN Standard for the development of Deep Learning methods.
|
| Products & Services | Product:
„Prostate.Carcinoma.ai“ is the smart power-up for PACS and diagnostic DICO viewers. “Prostate.Carcinoma.ai” offers automatic voxel-wise segmentations of the prostate, their zones as well as segmentation of suspicious lesions. This leads to a reduction of the radiologists workflow, to more accurate prostate volumetry and to an increased time efficiency.
„Prostate.Carcinoma.ai“ is certified according to (EU) MDR 2017/745 IIa since Dec 2023.
Research and Development:
FUSE-AI is involved in research projects with well-known university hospitals and institutes in Germany (Hamburg, Jena, and Berlin) and Switzerland (Aarau, Zurich, Bellinzona e Valli).
|
| References and export activities | The deployment of “Prostate.Carcinoma.ai” has started recently in 6 hospitals in Germany in cooperation with one of leading radiological platforms in Germany.
Our sales strategy intends to sell to 44 countries worldwide this year with MDSAP and FDA certification.
|
| Target group | We are looking for PACS vendors and clinics which like to redefine (prostate) MRI analysis with us.
|
| Competitive advantages | Using “Prostate.Carcinoma.ai” means to enhance your own business:
– provide new AI-based functions to the customer base and address new customers
– benefit from the fast and seamless integration of the containerized analysis module into your trusted diagnostic software
– achieve low risk due to the medical device responsibility of certified software
|
| Ideal Business Partners | PACS vendors, decision makers in clinics
|
